{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:57:02Z","timestamp":1794959822332,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli studi \"Magna Graecia\" di Catanzaro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The uric acid-to-HDL cholesterol ratio (UHR) is a promising non-insulin-based marker for metabolic risk, associated with type 2 diabetes, hypertension, hepatic steatosis, and cardiovascular disease. However, its utility in individuals with altered glucose tolerance remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We investigated the relationship between UHR and insulin sensitivity in two independent cohorts. Sample 1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091555) from the CATAMERI study, was stratified based on oral glucose tolerance test (OGTT) results, and Sample 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009332) from the EUGENE2 project, with insulin sensitivity measured via euglycemic-hyperinsulinemic clamp.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In Sample 1, UHR showed positive correlations with BMI, triglycerides, 2-hour plasma glucose, HOMA-IR, fasting plasma insulin (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001 for all) and with HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and negative correlations with Matsuda index (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and total cholesterol (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019). Multivariable linear regression identified HOMA-IR (\u03b2\u2009=\u20090.100), Matsuda index (\u03b2=-0.146), InsAUC30\/GluAUC30 (\u03b2\u2009=\u20090.120), and Stumvoll 1st-phase insulin secretion (\u03b2\u2009=\u20090.121) as independent UHR predictors. In Sample 2, bivariate analyses, adjusted for age, sex, and BMI, confirmed positive correlations between UHR and HbA1c (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), 2-hour post-load glucose (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), BMI, triglycerides, and fasting insulin (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001 for all) and a negative correlation with Clamp M (glucose disposal,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003). Finally, multivariable regression of Clamp M variability (adjusted for age, sex, and BMI) demonstrated significant negative associations with UHR (\u03b2= -0.230) and BMI (\u03b2= -0.375).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that UHR, derived easily and inexpensively from routine clinical measurements, is a promising indicator of metabolic risk in individuals without diabetes. Its accessibility positions it as a potential tool for early diabetes prevention strategies, potentially reducing reliance on the OGTT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00592-025-02576-2","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:10:55Z","timestamp":1756285855000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Serum uric acid to HDL-Chol ratio (UHR) is associated with insulin resistance\/sensitivity in individuals without diabetes"],"prefix":"10.1007","volume":"63","author":[{"given":"Mariangela","family":"Rubino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Averta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Palummo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Succurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia Chiara","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2576_CR1","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s40200-020-00641-x","volume":"19","author":"D Himanshu","year":"2020","unstructured":"Himanshu D, Ali W, Wamique M (2020) Type 2 diabetes mellitus: pathogenesis and genetic diagnosis. J Diabetes Metab Disord 19:1959\u20131966. https:\/\/doi.org\/10.1007\/s40200-020-00641-x","journal-title":"J Diabetes Metab Disord"},{"key":"2576_CR2","volume-title":"IDF diabetes atlas 10th edition scientific committee. IDF DIABETES ATLAS","author":"DJ Magliano","year":"2021","unstructured":"Magliano DJ, Boyko EJ (2021) IDF diabetes atlas 10th edition scientific committee. IDF DIABETES ATLAS, 10th edn. International Diabetes Federation, Brussels","edition":"10"},{"key":"2576_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc24-SINT","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee (2024) Introduction and methodology: standards of care in Diabetes-2024. Diabetes Care 47:S1\u20134. https:\/\/doi.org\/10.2337\/dc24-SINT","journal-title":"Diabetes Care"},{"key":"2576_CR4","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M et al (2010) The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95:3347\u20133351. https:\/\/doi.org\/10.1210\/jc.2010-0288","journal-title":"J Clin Endocrinol Metab"},{"key":"2576_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","volume":"32","author":"D-H Son","year":"2022","unstructured":"Son D-H, Lee HS, Lee Y-J et al (2022) Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis 32:596\u2013604. https:\/\/doi.org\/10.1016\/j.numecd.2021.11.017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2576_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D et al (2018) METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol 178:533\u2013544. https:\/\/doi.org\/10.1530\/EJE-17-0883","journal-title":"Eur J Endocrinol"},{"key":"2576_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.numecd.2023.12.022","volume":"34","author":"G Bazmandegan","year":"2024","unstructured":"Bazmandegan G, Dehghani MH, Karimifard M et al (2024) Uric acid to HDL ratio: A marker for predicting incidence of metabolic syndrome in patients with type II diabetes. Nutr Metab Cardiovasc Dis 34:1014\u20131020. https:\/\/doi.org\/10.1016\/j.numecd.2023.12.022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2576_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12872-020-01771-z","volume":"21","author":"T Kou","year":"2021","unstructured":"Kou T, Luo H, Yin L (2021) Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis. BMC Cardiovasc Disord 21:127. https:\/\/doi.org\/10.1186\/s12872-020-01771-z","journal-title":"BMC Cardiovasc Disord"},{"key":"2576_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S et al (2016) Regulation of uric acid metabolism and excretion. Int J Cardiol 213:8\u201314. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.109","journal-title":"Int J Cardiol"},{"key":"2576_CR10","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.2337\/db12-1814","volume":"62","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Sanchez-Lozada LG et al (2013) Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62:3307\u20133315. https:\/\/doi.org\/10.2337\/db12-1814","journal-title":"Diabetes"},{"key":"2576_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","volume":"71","author":"RJ Johnson","year":"2018","unstructured":"Johnson RJ, Bakris GL, Borghi C et al (2018) Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National kidney foundation. Am J Kidney Dis 71:851\u2013865. https:\/\/doi.org\/10.1053\/j.ajkd.2017.12.009","journal-title":"Am J Kidney Dis"},{"key":"2576_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40620-020-00702-7","volume":"33","author":"B Bonino","year":"2020","unstructured":"Bonino B, Leoncini G, Russo E et al (2020) Uric acid in CKD: has the jury come to the verdict? J Nephrol 33:715\u2013724. https:\/\/doi.org\/10.1007\/s40620-020-00702-7","journal-title":"J Nephrol"},{"key":"2576_CR13","doi-asserted-by":"publisher","unstructured":"Kosekli MA, Kurtkulagii O, Kahveci G et al The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras ((1992)). 2021;67:549\u201354. doi: ). 2021;67:549\u201354. https:\/\/doi.org\/10.1590\/1806-9282.20201005","DOI":"10.1590\/1806-9282.20201005"},{"key":"2576_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/00325481.2023.2214058","volume":"135","author":"G Aktas","year":"2023","unstructured":"Aktas G, Yilmaz S, Kantarci DB et al (2023) Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med 135:519\u2013523. https:\/\/doi.org\/10.1080\/00325481.2023.2214058","journal-title":"Postgrad Med"},{"key":"2576_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00325481.2022.2039007","volume":"134","author":"G Aktas","year":"2022","unstructured":"Aktas G, Khalid A, Kurtkulagi O et al (2022) Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med 134:297\u2013302. https:\/\/doi.org\/10.1080\/00325481.2022.2039007","journal-title":"Postgrad Med"},{"key":"2576_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2478\/rjim-2021-0023","volume":"59","author":"O Kurtkulagi","year":"2021","unstructured":"Kurtkulagi O, Tel BMA, Kahveci G et al (2021) Hashimoto\u2019s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med 59:403\u2013408. https:\/\/doi.org\/10.2478\/rjim-2021-0023","journal-title":"Rom J Intern Med"},{"key":"2576_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jdi.14170","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou X, Xu J (2024) Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis. J Diabetes Investig 15:762\u2013771. https:\/\/doi.org\/10.1111\/jdi.14170","journal-title":"J Diabetes Investig"},{"key":"2576_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/dc11-2339","volume":"35","author":"CS Tam","year":"2012","unstructured":"Tam CS, Xie W, Johnson WD et al (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35:1605\u20131610. https:\/\/doi.org\/10.2337\/dc11-2339","journal-title":"Diabetes Care"},{"key":"2576_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/dmrr.724","volume":"23","author":"F Andreozzi","year":"2007","unstructured":"Andreozzi F, Succurro E, Mancuso MR et al (2007) Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110\u00a0mg\/dl threshold. Diabetes Metab Res Rev 23:547\u2013550. https:\/\/doi.org\/10.1002\/dmrr.724","journal-title":"Diabetes Metab Res Rev"},{"key":"2576_CR20","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2002-021716","volume":"88","author":"MA Marini","year":"2003","unstructured":"Marini MA, Frontoni S, Mineo D et al (2003) The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 88:3368\u20133371. https:\/\/doi.org\/10.1210\/jc.2002-021716","journal-title":"J Clin Endocrinol Metab"},{"key":"2576_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1080\/13685538.2019.1678126","volume":"23","author":"G Aktas","year":"2020","unstructured":"Aktas G, Kocak MZ, Bilgin S et al (2020) Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male 23:1098\u20131102. https:\/\/doi.org\/10.1080\/13685538.2019.1678126","journal-title":"Aging Male"},{"key":"2576_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"2576_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"2576_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295\u2013301. https:\/\/doi.org\/10.2337\/diacare.23.3.295","journal-title":"Diabetes Care"},{"key":"2576_CR25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.2337\/dc11-2170","volume":"35","author":"LB Harrison","year":"2012","unstructured":"Harrison LB, Adams-Huet B, Raskin P et al (2012) \u03b2-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 35:1406\u20131412. https:\/\/doi.org\/10.2337\/dc11-2170","journal-title":"Diabetes Care"},{"key":"2576_CR26","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214\u2013223. https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214","journal-title":"Am J Physiol"},{"key":"2576_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"2576_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.15420\/ecr.2016:4:2","volume":"11","author":"ML Muiesan","year":"2016","unstructured":"Muiesan ML, Agabiti-Rosei C, Paini A et al (2016) Uric acid and cardiovascular disease: an update. Eur Cardiol Rev 11:54. https:\/\/doi.org\/10.15420\/ecr.2016:4:2","journal-title":"Eur Cardiol Rev"},{"key":"2576_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ (2008) Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27:608\u2013619. https:\/\/doi.org\/10.1080\/15257770802138558","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2576_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/dom.14570","volume":"24","author":"X Hu","year":"2022","unstructured":"Hu X, Yang Y, Hu X et al (2022) Effects of sodium-glucose cotransporter 2 inhibitors on serum uric acid in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis. Diabetes Obes Metab 24:228\u2013238. https:\/\/doi.org\/10.1111\/dom.14570","journal-title":"Diabetes Obes Metab"},{"key":"2576_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40200-015-0200-z","volume":"14","author":"S Nejatinamini","year":"2015","unstructured":"Nejatinamini S, Ataie-Jafari A, Qorbani M et al (2015) Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord 14:70. https:\/\/doi.org\/10.1186\/s40200-015-0200-z","journal-title":"J Diabetes Metab Disord"},{"key":"2576_CR32","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41440-020-0481-6","volume":"43","author":"MA Lanaspa","year":"2020","unstructured":"Lanaspa MA, Andres-Hernando A, Kuwabara M (2020) Uric acid and hypertension. Hypertens Res 43:832\u2013834. https:\/\/doi.org\/10.1038\/s41440-020-0481-6","journal-title":"Hypertens Res"},{"key":"2576_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cdtm.2016.09.003","volume":"2","author":"Y-L Xu","year":"2016","unstructured":"Xu Y-L, Xu K-F, Bai J-L et al (2016) Elevation of serum uric acid and incidence of type 2 diabetes: A systematic review and meta-analysis. Chronic Dis Transl Med 2:81\u201391. https:\/\/doi.org\/10.1016\/j.cdtm.2016.09.003","journal-title":"Chronic Dis Transl Med"},{"key":"2576_CR34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","volume":"37","author":"R Spiga","year":"2017","unstructured":"Spiga R, Marini MA, Mancuso E et al (2017) Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-\u03baB signaling pathway in HepG2 cells. Arterioscler Thromb Vasc Biol 37:1241\u20131249. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309128","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2576_CR35","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.3390\/ijms232012325","volume":"23","author":"R La Grotta","year":"2022","unstructured":"La Grotta R, Frig\u00e9 C, Matacchione G et al (2022) Repurposing SGLT-2 inhibitors to target aging: available evidence and molecular mechanisms. Int J Mol Sci 23:12325. https:\/\/doi.org\/10.3390\/ijms232012325","journal-title":"Int J Mol Sci"},{"key":"2576_CR36","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/dom.14081","volume":"22","author":"F Prattichizzo","year":"2020","unstructured":"Prattichizzo F, Giuliani A, Sabbatinelli J et al (2020) Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes. Diabetes Obes Metab 22:1696\u20131700. https:\/\/doi.org\/10.1111\/dom.14081","journal-title":"Diabetes Obes Metab"},{"key":"2576_CR37","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/nu11102460","volume":"11","author":"R Spiga","year":"2019","unstructured":"Spiga R, Mannino GC, Mancuso E et al (2019) Are Circulating Mg2\u2009+\u2009Levels associated with glucose tolerance profiles and incident type 2 diabetes?? Nutrients 11:2460. https:\/\/doi.org\/10.3390\/nu11102460","journal-title":"Nutrients"},{"key":"2576_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.numecd.2015.02.007","volume":"25","author":"TV Fiorentino","year":"2015","unstructured":"Fiorentino TV, Hribal ML, Andreozzi F et al (2015) Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals. Nutr Metab Cardiovasc Dis 25:510\u2013517. https:\/\/doi.org\/10.1016\/j.numecd.2015.02.007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2576_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00592-014-0647-2","volume":"52","author":"TV Fiorentino","year":"2015","unstructured":"Fiorentino TV, Hribal ML, Perticone M et al (2015) Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American diabetes association criteria. Acta Diabetol 52:349\u2013356. https:\/\/doi.org\/10.1007\/s00592-014-0647-2","journal-title":"Acta Diabetol"},{"key":"2576_CR40","doi-asserted-by":"publisher","first-page":"10891","DOI":"10.3390\/ijms231810891","volume":"23","author":"M Perticone","year":"2022","unstructured":"Perticone M, Maio R, Gigliotti S et al (2022) Immuno-Mediated inflammation in hypertensive patients with 1-h Post-Load hyperglycemia. Int J Mol Sci 23:10891. https:\/\/doi.org\/10.3390\/ijms231810891","journal-title":"Int J Mol Sci"},{"key":"2576_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fendo.2018.00098","volume":"9","author":"EJ Tassone","year":"2018","unstructured":"Tassone EJ, Cimellaro A, Perticone M et al (2018) Uric acid impairs insulin signaling by promoting Enpp1 binding to insulin receptor in human umbilical vein endothelial cells. Front Endocrinol (Lausanne) 9:98. https:\/\/doi.org\/10.3389\/fendo.2018.00098","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2576_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","volume":"26","author":"SM Grundy","year":"2016","unstructured":"Grundy SM (2016) Metabolic syndrome update. Trends Cardiovasc Med 26:364\u2013373. https:\/\/doi.org\/10.1016\/j.tcm.2015.10.004","journal-title":"Trends Cardiovasc Med"},{"key":"2576_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10557-018-06846-w","volume":"33","author":"ST Chiesa","year":"2019","unstructured":"Chiesa ST, Charakida M (2019) High-Density lipoprotein function and dysfunction in health and disease. Cardiovasc Drugs Ther 33:207\u2013219. https:\/\/doi.org\/10.1007\/s10557-018-06846-w","journal-title":"Cardiovasc Drugs Ther"},{"key":"2576_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fphar.2015.00258","volume":"6","author":"AL Siebel","year":"2015","unstructured":"Siebel AL, Heywood SE, Kingwell BA (2015) HDL and glucose metabolism: current evidence and therapeutic potential. Front Pharmacol 6:258. https:\/\/doi.org\/10.3389\/fphar.2015.00258","journal-title":"Front Pharmacol"},{"key":"2576_CR45","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","volume":"263","author":"SM Haffner","year":"1990","unstructured":"Haffner SM, Stern MP, Hazuda HP et al (1990) Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893\u20132898","journal-title":"JAMA"},{"key":"2576_CR46","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.2337\/dc13-2738","volume":"37","author":"B Waldman","year":"2014","unstructured":"Waldman B, Jenkins AJ, Davis TME et al (2014) HDL-C and HDL-C\/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care 37:2351\u20132358. https:\/\/doi.org\/10.2337\/dc13-2738","journal-title":"Diabetes Care"},{"key":"2576_CR47","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","volume":"119","author":"BG Drew","year":"2009","unstructured":"Drew BG, Duffy SJ, Formosa MF et al (2009) High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 119:2103\u20132111. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.843219","journal-title":"Circulation"},{"key":"2576_CR48","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00125-007-0642-z","volume":"50","author":"A Abderrahmani","year":"2007","unstructured":"Abderrahmani A, Niederhauser G, Favre D et al (2007) Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 50:1304\u20131314. https:\/\/doi.org\/10.1007\/s00125-007-0642-z","journal-title":"Diabetologia"},{"key":"2576_CR49","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1161\/ATVBAHA.110.207373","volume":"30","author":"MA Fryirs","year":"2010","unstructured":"Fryirs MA, Barter PJ, Appavoo M et al (2010) Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol 30:1642\u20131648. https:\/\/doi.org\/10.1161\/ATVBAHA.110.207373","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2576_CR50","doi-asserted-by":"publisher","first-page":"e3289","DOI":"10.1002\/dmrr.3289","volume":"36","author":"TV Fiorentino","year":"2020","unstructured":"Fiorentino TV, Succurro E, Marini MA et al (2020) HDL cholesterol is an independent predictor of \u03b2-cell function decline and incident type 2 diabetes: A longitudinal study. Diabetes Metab Res Rev 36:e3289. https:\/\/doi.org\/10.1002\/dmrr.3289","journal-title":"Diabetes Metab Res Rev"},{"key":"2576_CR51","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nm1546","volume":"13","author":"LR Brunham","year":"2007","unstructured":"Brunham LR, Kruit JK, Pape TD et al (2007) Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to Thiazolidinedione treatment. Nat Med 13:340\u2013347. https:\/\/doi.org\/10.1038\/nm1546","journal-title":"Nat Med"},{"key":"2576_CR52","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1172\/JCI41280","volume":"120","author":"JM Sturek","year":"2010","unstructured":"Sturek JM, Castle JD, Trace AP et al (2010) An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. J Clin Invest 120:2575\u20132589. https:\/\/doi.org\/10.1172\/JCI41280","journal-title":"J Clin Invest"},{"key":"2576_CR53","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1161\/ATVBAHA.120.314640","volume":"40","author":"E Mancuso","year":"2020","unstructured":"Mancuso E, Mannino GC, Fuoco A et al (2020) HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) potentially modulate pancreatic \u03b1-Cell glucagon secretion. Arterioscler Thromb Vasc Biol 40:2941\u20132952. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314640","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2576_CR54","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1194\/jlr.M032904","volume":"54","author":"J Dalla-Riva","year":"2013","unstructured":"Dalla-Riva J, Stenkula KG, Petrlova J et al (2013) Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle. J Lipid Res 54:1275\u20131282. https:\/\/doi.org\/10.1194\/jlr.M032904","journal-title":"J Lipid Res"},{"key":"2576_CR55","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1161\/01.CIR.0000091339.70120.53","volume":"108","author":"A Festa","year":"2003","unstructured":"Festa A, Hanley AJG, Tracy RP et al (2003) Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108:1822\u20131830. https:\/\/doi.org\/10.1161\/01.CIR.0000091339.70120.53","journal-title":"Circulation"},{"key":"2576_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1210\/jc.2004-1133","volume":"90","author":"E Ferrannini","year":"2005","unstructured":"Ferrannini E, Gastaldelli A, Miyazaki Y et al (2005) beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493\u2013500. https:\/\/doi.org\/10.1210\/jc.2004-1133","journal-title":"J Clin Endocrinol Metab"},{"key":"2576_CR57","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/diacare.2951130","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130\u20131139. https:\/\/doi.org\/10.2337\/diacare.2951130","journal-title":"Diabetes Care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02576-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:11:56Z","timestamp":1769515916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02576-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02576-2","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local Ethics Committee of the University Magna Graecia of Catanzaro (approval code: 2012.63) and written informed consent was obtained from each subject before commencing the studies, in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}